Results 281 to 290 of about 1,133,038 (343)

Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin   +2 more
wiley   +1 more source

Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer   +14 more
wiley   +1 more source

Unlocking the power of groups in youth sport: a proof-of-concept evaluation of the Together For Us (T4Us) intervention. [PDF]

open access: yesPilot Feasibility Stud
Bruner MW   +8 more
europepmc   +1 more source

Redesigning mental health research systems from within: the role of peer-led co-production. [PDF]

open access: yesFront Health Serv
D'souza NA   +11 more
europepmc   +1 more source

A Descriptive Phenomenological Inquiry of Nurse Educators' Leadership Practices and Styles During Pandemic Crisis in Saudi Arabia. [PDF]

open access: yesNurs Open
Salvador JT   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy